Randomized feasibility study of an autologous protein solution versus corticosteroids injection for treating subacromial pain in the primary care setting - the SPiRIT trial.
Alex WoodsAnthony J HowardNicholas PeckhamInes RombachAsma SalehJuul AchtenDuncan E AppelbePraveen ThamattoreStephen E GwilymPublished in: Bone & joint open (2024)
Our study shows that it is feasible to recruit to a patient-blinded randomized controlled trial comparing APS and CSI for subacromial pain in terms of clinical outcomes and health-resource use in the UK. Safety and efficacy data are presented.
Keyphrases
- study protocol
- randomized controlled trial
- primary care
- chronic pain
- phase iii
- placebo controlled
- pain management
- neuropathic pain
- phase ii
- open label
- double blind
- clinical trial
- healthcare
- public health
- mental health
- case report
- bone marrow
- health information
- cross sectional
- cell therapy
- spinal cord
- binding protein
- social media
- postoperative pain
- small molecule
- systematic review
- risk assessment
- protein protein
- general practice
- artificial intelligence